Wednesday, July 8, 2026

pharma · Coronary Artery Bypass Grafting · Hypertension Pulmonary Secondary · TENX

TENAX THERAPEUTICS

TENAX THERAPEUTICS clinical programs — 0 development programs from ClinicalTrials.gov with phase, modality, indication, and trial identifiers.

Chapel Hill, USA HQ
19 Employees
Public company Type
TENX · NYSE Ticker
Company details
Status
Public
HQ
Chapel Hill, USA
Employees
19
Programs
7
Drugs
2
Patents
4
Intelligence · Clinical Programs

TENAX THERAPEUTICS projects

0 ClinicalTrials.gov programs sponsored by TENAX THERAPEUTICS.

TENAX THERAPEUTICS has 0 clinical development programs indexed from ClinicalTrials.gov, including phase, modality, indication text, and linked NCT identifiers.

No programs matched

Try a different phase filter or check back as we index more trials.

Frequently asked questions

How many clinical projects does TENAX THERAPEUTICS have?

0 published programs are linked to this sponsor in our ClinicalTrials.gov index.

Is this the complete company pipeline?

This directory lists published programs for the sponsor in our database. Partnered or out-licensed assets may appear under multiple companies.